DTx in Medical – Thematic Intelligence

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Reasons to buy the ‘DTx in Medical’ thematic intelligence report:

  • Identify the companies most likely to succeed in a world filled with disruptive threats.
  • Predict how each theme will evolve and identify the leading and disrupting companies.
  • Get an overview of the digital therapeutics theme.
  • Analyze the emerging technological, macroeconomic, and regulatory trends shaping the DTx in medical theme and understand their broader impact on the market.

How is our ‘DTx in Medical’ report unique from other reports in the market?

  • Develop and design your corporate strategies through an in-house expert analysis of digital therapeutics.
  • Understand the primary ways in which this theme is impacting the healthcare industry.
  • Stay up to date on the industry’s major players and where they sit in the value chain.
  • Identify emerging industry trends to gain a competitive advantage.

We recommend this valuable source of information to anyone involved in: 

  • ​Medical Device Companies
  • Health Tech Companies
  • Tech Startups and Leaders
  • Researchers and Academics
  • Consulting Firms/Investing Firms
  • Venture Capital/Equity Firms

To Get a Snapshot of the DTx in Medical Thematic Report

Download a Free Report Sample

DTX in Medical Thematic Report Overview

Digital therapeutics (DTx) are software-based interventions that deliver evidence-based therapeutic interventions to patients. The interventions are driven by high-quality software programs to prevent, manage, or treat a medical condition. The majority of DTx are designed to treat chronic, respiratory, and mental health or neurological conditions. The use of DTx generally requires a prescription, as the interventions must be cleared or certified by regulatory bodies to support their claims.

The DTx in medical thematic intelligence report is a thematic brief, which identifies companies most likely to succeed in a world filled with disruptive threats. In the report, we predict how each theme will evolve and identify the leading and disrupting companies.

Report Pages 38
Regions Covered Global
Key Value Chain Components ·        DTx Markets

·        Services

·        Experience

Key Trends ·        Technology Trends

·        Macroeconomic Trends

·        Regulatory Trends

Leading Public Companies ·        Adherium

·        AstraZeneca

·        Better Therapeutics

·        DarioHealth

·        ResMed

·        Teladoc Health

Leading Private Companies ·        Amiko Digital Health

·        Big Health

·        Biofourmis

·        CureApp

·        Kaia Health

·        Sword Health

·        Twill

·        Voluntis

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

DTx in Medical – Key Trends

The primary trends that will shape the DTx theme over the next 12-24 months are classified into technology trends, macroeconomic trends, and regulatory trends.

  • Technology trends: The key technology trends impacting the DTx theme are the implementation of AI, the use of remote-patient monitoring, and wearable technology, among others.
  • Macroeconomic trends: Increasing healthcare costs, an aging population, and public health emergencies among others are macroeconomic trends expected to drive the DTx market in the coming years.
  • Regulatory trends: The rise in software as a medical device regulation is a key regulatory trend impacting the DTx market. For instance, In Europe, the new Medical Device Regulation and In Vitro Diagnostic Device Regulation include a medical device software (MDSW) consideration. A software digital health app will qualify as a “medical device” if it is intended to be used for one or more of the medical purposes specified in the definition of a medical device or in vitro diagnostic, which includes the diagnosis, treatment, and monitoring of a disease, injury, or disability.

DTx in Medical – Industry Analysis

There are 733 DTx pipeline products, and nervous system conditions are the most common therapy area for DTx products. Indications associated with nervous system diseases include chronic pain, generalized anxiety disorder, social anxiety disorder, major depressive disorder, alcohol use disorder, ADHD, and speech disorder.

A majority of the devices in the pipeline products database are expected to be approved during 2024-2027, however, a few are also expected to be approved in 2028 and 2029

The in DTx analysis also covers:

  • Timeline
  • Signals
  • M&A trends
    • Venture financing trends
    • Patent trends
    • Company filing trends

DTx Pipeline Products By Therapy Area

DTx Pipeline Products By Therapy Area

Buy the Full Report for More Insights into the DTx Theme in the Medical Market

Download a Free Report Sample

DTx in Medical - Value Chain Analysis

The DTx value chain can be split into the DTx markets, services, and experience.

DTx Markets: DTx markets is further segmented into chronic conditions, respiratory conditions, and mental health and neurological conditions.

Chronic conditions are long-term health issues that persist over an extended period of time and require ongoing medical attention. The symptoms of chronic conditions can range from relatively mild to severe, and they can have an impact on a patient’s life, including physical and mental health, daily functioning, and overall quality of life.

Power Industry Value Chain Analysis

Power Industry Value Chain Analysis

Buy the Full Report for More Insights into the DTx Value Chain

Download a Free Report Sample

DTx– Competitive Landscape

A few leading DTx public companies making their mark within the DTx theme are:

  • Adherium
  • AstraZeneca
  • Better Therapeutics
  • DarioHealth

Adherium is a digital health company that offers smart devices to treat patients suffering from respiratory conditions such as asthma and COPD. Adherium’s DTx solution, Hailie, enables patients to control their respiratory conditions by tracking medication usage and obtaining alerts on timely medication intake.

A few leading DTx private companies making their mark within the DTx theme are:

  • Amiko Digital Health
  • Big Health
  • Biofourmis

Amiko Digital Health is a developer of AI digital health tools and medication sensor technologies used by healthcare providers. Amiko’s first product is Respiro, a digital medicine product that uses sensors built into inhalers to record usage and measure inhalation flow.

Buy the Full Report to Know More About the Leading Companies in the DTx Market

Download a Free Report Sample

Medical Devices Sector Scorecard

At GlobalData, we use a scorecard approach to predict tomorrow’s leading companies within each sector. Our power sector scorecard has three screens: a thematic screen, a valuation screen, and a risk screen.

  • The thematic screen ranks companies based on overall leadership in the 10 themes that matter most to their industry, generating a leading indicator of future performance.
  • The valuation screen ranks our universe of companies within a sector based on selected valuation metrics.
  • The risk screen ranks companies within a particular sector based on overall investment risk.

Medical Devices Sector Scorecard – Thematic Screen

Medical Devices Sector Scorecard – Thematic Screen

Buy the Full Report to Know More About the Sector Scorecards

Download a Free Report Sample

Omada Health
Teledoc Health
Sword Health
Click Therapeutics
Kaia Health
Akili Interactive
Big Health

Table of Contents

  • 1. Executive Summary
  • 2. Players
  • 3. Thematic Briefing
  • 4. Trends

    • 4.1. Technology trends
    • 4.2. Macroeconomic trends
    • 4.3. Regulatory trends

  • 5. Industry Analysis

    • 5.1. Market size and growth forecasts
    • 5.2. Timeline

  • 6. Signals

    • 6.1. M&A trends
    • 6.2. Venture financing trends
    • 6.3. Patent trends
    • 6.4. Company filing trends

  • 7. Value Chain

    • 7.1. DTx markets
    • 7.2. Services
    • 7.3. Experience

  • 8. Companies
  • 9. Sector Scorecard

    • 9.1. Medical devices sector scorecard

  • 10. Glossary
  • 11. Further Reading
  • 12. Our Thematic Research Methodology
  • 13. About GlobalData
  • 14. Contact Us

Frequently asked questions

DTx in Medical – Thematic Intelligence thematic reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

DTx in Medical – Thematic Intelligence was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at DTx in Medical – Thematic Intelligence in real time.

  • Access a live DTx in Medical – Thematic Intelligence dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.